Search

everythinglearnresearchcommunity

for

Search:↓

The article concludes that schoolchildren and adolescents experienced various skin issues during the COVID-19 pandemic, including acne from masks and other skin reactions from the virus and vaccines.

Skin issues can indicate immune system problems.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

Topical tofacitinib is effective in promoting hair growth for non-scarring alopecia.

Substances from Chinese medicines show promise for immune support and disease prevention, but the way they are processed affects their effectiveness.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

New treatments focusing on immune pathways show promise for stubborn hair loss.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

Eating a high-fat fish oil diet caused mice to lose hair due to a specific immune cell activity in the skin linked to a protein called E-FABP.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

The article concludes that developing in vitro models for human hair structures is important for research and reducing animal testing, but there are challenges like obtaining suitable samples and the models' limitations.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

White blood cells and their traps can slow down the process of new hair growth after a wound.

The symposium concluded that a specific lipid might cause hair loss, inflammation is a key factor, and stem cells in bald scalps aren't working right, suggesting new treatment targets.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Acne is a temporary skin imbalance during puberty that often resolves on its own.

TLR4 is important in aging-related diseases and could be a new treatment target.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

Finasteride may help treat kidney disease caused by a high-fat diet by reducing harmful toxins and improving gut bacteria.

Asparagus racemosus and Withania somnifera can help reduce side effects of a cancer drug.

Adding insulin-like growth factor 1 and bone marrow-derived stem cells to a collagen-chitosan scaffold helps wounds heal faster and regrows hair follicles.

The Chinese herbal supplement BeauTop can potentially boost hair growth and thickness by increasing a protein called Vascular Endothelial Growth Factor.

Alopecia Areata is linked to specific gut bacteria and metabolites, indicating a complex gut microbiome.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

TSLP affects atopic dermatitis by increasing sebum and reducing fat through IL-4/IL-13 signaling.

New treatments like JAK inhibitors show promise for reversing alopecia areata.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.